Reprieve Cardiovascular is led by a seasoned management team with extensive experience in the medical device industry.
Location: United States, Massachusetts, Milford
Employees: 51-200
Total raised: $42M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 11.08.2020 | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.02.2024 | Series A | $42M | - |
Mentions in press and media 9
| Date | Title | Description |
| 27.08.2025 | Reprieve Cardiovascular Raises $61M in Series B Financing | Reprieve Cardiovascular, a Milford, MA-based clinical-stage company pioneering intelligent decongestion management therapy for acute decompensated heart failure (ADHF), raised $61M in Series B funding. The round was led by Deerfield Managem... |
| 13.08.2025 | Reprieve Cardiovascular Raises $61M to Fund Pivotal Heart Failure Trial | What You Should Know: – Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures,... |
| 23.02.2024 | Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M Funding | Reprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis... |
| 22.02.2024 | Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure | What You Should Know: – Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round. – The Series A round was co-led b... |
| 20.02.2024 | Reprieve Cardiovascular Raises $42M in Series A Financing | Reprieve Cardiovascular, a Milford, MA-based development stage company focused on an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, raised $42M in Series A funding. The r... |
| 20.02.2024 | Reprieve Cardiovascular Launches With $42M | MILFORD, MA, Reprieve Cardiovascular today announced it has raised a total of $42 million in series A financing. >> Click here for more funding data on Reprieve Cardiovascular >> To export Reprieve Cardiovascular funding dat... |
| 13.09.2018 | Term Sheet — Thursday, September 13 | A SUMMER OF PROMOTIONS Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop In January, BoxGroup promoted Nimi Katragadda to partner. In May, Bain Capital Ventures hired Sarah Smith as a ge... |
| - | Reprieve Cardiovascular | “Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.” |
| - | Reprieve Cardiovascular | “Improving Outcomes for CHF Patients” |